Goncalves Joana Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$214,293.02

Insider Activity of Goncalves Joana

According to the SEC Form 4 filings, Goncalves Joana, being in a position of

  1. Chief Medical Officer at Oruka Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 79535 shares for $5.07M,
    over all time since 2025-12-19, has bought 0 shares, and sold 79535 shares for $5.07M.

Biography of Goncalves Joana

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$5,067,10011100

Comparison of Insiders on Amount of Buys and Sells

2026-10-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0107%
$74.81$523,648+22.28%
2026-09-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,947
0.0132%
$92.38$734,145-8.69%
2026-08-17SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0111%
$111.84$782,882-18.67%
2026-07-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0184%
$86.28$603,938+6.69%
2026-06-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,947
0.021%
$69.28$550,607+33.08%
2026-05-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0181%
$61.85$432,935+42.37%
2026-04-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0194%
$66.12$462,830+28.88%
2026-03-16SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,641
0.02%
$40.91$312,560+96.67%
2026-02-17SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0185%
$32.37$226,559+137.87%
2026-01-15SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.0183%
$31.81$222,704+114.74%
2025-12-19SaleOruka Therapeutics, Inc.
ORKA
Chief Medical Officer
7,000
0.021%
$30.61$214,293+114.95%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.